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1594Objectives: Carbon monoxide is produced endogenously as a by-product of heme catalysis and has been shown
to reduce ischemia–reperfusion injury in a variety of organs in murine models. The aims of this translational
research were to establish an in situ porcine lung model of warm ischemia–reperfusion injury and to evaluate
the cytoprotective effects of low-dose inhaled carbon monoxide in this model.
Methods: Warm ischemia was induced for 90 minutes by clamping the left pulmonary artery and veins in 8 Clawn
miniature swine (Japan Farm CLAWN Institute, Kagoshima, Japan). The left main bronchus was also dissected
and reanastomosed just before reperfusion. Four animals were treated with inhaled carbon monoxide at a concen-
tration of approximately 250 ppm throughout the procedure. Lung function and structure were serially accessed
via lung biopsy, chest x-ray films, and blood gas analysis.
Results: Carbon monoxide inhalation dramatically decreased the lung injury associated with ischemia and reper-
fusion. Two hours after reperfusion, the arterial oxygen tension of the carbon monoxide–treated group was 454
34 mm Hg, almost double the arterial oxygen tension of the control group (227  57 mm Hg). There were fewer
pathologic changes seen on chest x-ray films and in biopsy samples from animals in the carbon monoxide–treated
group. Animals in the carbon monoxide–treated group also had fewer inflammatory cell infiltrates and a markedly
smaller increase in serum concentrations of the proinflammatory cytokines interleukin 1b, interleukin 6, and high-
mobility group box 1 after ischemia–reperfusion injury.
Conclusions: The perioperative administration of low-dose inhaled carbon monoxide decreases warm ischemia–
reperfusion injury in lungs in miniature swine. This protective effect is mediated in part by the downregulation of
proinflammatory mediators. (J Thorac Cardiovasc Surg 2010;139:1594-601)Ischemia–reperfusion injury (IRI) in the lungs is character-
ized by nonspecific alveolar damage, lung edema, and hyp-
oxemia within 72 hours of transplantation.1 Despite
advances in donor and recipient perioperative management,
surgical technique, and lung preservation, IRI continues to
be the most common cause of primary graft failure. Between
15% and 33% of lung transplants are affected by IRI,
frequently leading to recipient death after prolonged me-
chanical ventilation.2 Furthermore, patients with lung IRI
who survive the perioperative period remain at an increased
risk of both acute and chronic rejection.3,4 The shortage of
available organs for transplantation has increasingly led to
the use of organs from extended-criteria donors that are
more susceptible to severe IRI. As a result, the clinicale Xenotransplantation Surgery Section, Frontier Science Research Center,
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The Journal of Thoracic and Cardiovascular Surimpact of IRI has expanded. Strategies that reduce IRI
have the potential to expand the use of marginal organ
donors and improve both the short- and long-term outcomes
of transplantation.
Tissues exposed to stressful stimuli upregulate protective
genes such as heme oxygenase-1,5 which has been shown to
decrease both nonspecific inflammation and alloantigen-
specific immune responses to IRI6 and transplantation.7
Carbon monoxide (CO) has recently been shown to have
the same protective effects as the upregulation of heme
oxygenase-1. Although CO is commonly recognized as an
environmental air pollutant that displaces oxygen in the
blood and causes tissue hypoxia,8 it is also produced endog-
enously in response to heat or oxidant stress by the metabo-
lism of heme by heme oxygenases to CO, iron, and
biliverdin.9 Furthermore, the inhalation of low-dose CO at
concentrations between 20 and 500 parts per million
(ppm) has been shown to exert cytoprotective effects in
murine models of IRI and organ transplantation.10 CO deliv-
ered by CO-releasing molecules11,12 or in soluble form via
a preservation solution13 has been reported to exert similar
protective effects in murine IRI models.
Whereas CO has been shown to inhibit lung IRI in
a variety of organs in murine models, the beneficial effects
of CO on IRI in large animals have only been reported ingery c June 2010
Abbreviations and Acronyms
CO ¼ carbon monoxide
COHb ¼ carboxyhemoglobin
CXR ¼ chest x-ray
HMGB1 ¼ high-mobility group box 1
IRI ¼ ischemia–reperfusion injury
PaO2 ¼ arterial oxygen tension
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perfusion of an isolated kidney.15,16 CO has not yet been
studied in an in situ porcine pulmonary IRI model. Transla-
tional research using an accepted and relevant preclinical
species is necessary before the powerful therapeutic implica-
tions of this murine research can be applied in a clinical
setting. In this study, we demonstrate that the inhalation of
low-dose CO dramatically decreases warm IRI to native
lungs in miniature swine, in part through the downregulation
of proinflammatory mediators.
MATERIALS AND METHODS
Animals
Male and female Clawn miniature swine between 5 and 9 months of age
and weighing 10 to 15 kg were obtained from the Japan Farm CLAWN
Institute (Kagoshima, Japan). All animal care and procedures were
performed in accordance with the guidelines of the National Society for
Medical Research and the ‘‘Guide for the Care and Use of Laboratory
Animals’’ prepared by the Institute of Laboratory Animal Resources and
published by the National Institutes of Health. The study protocol was
approved by the Ethical Committee of the Faculty of Medicine at Kagosh-
ima University in Japan.
CO Inhalation
CO (1%) in oxygen was directed into the isoflurane vaporizer and deliv-
ered to the animals via the inhaled anesthesia machine. A CO analyzer (CO
checker YZ-005A; Yazaki Co Ltd, Tokyo, Japan) was used to continuously
measure CO levels in the inhaled gas and maintain a CO concentration of
250 ppm at all times. The percentage of carboxyhemoglobin (COHb) in
arterial blood was measured by a CO-Oximeter (CCX1 with CO-Oximeter;
Nova Biomedical, Tokyo, Japan).
Experimental Design
Eight miniature swine were divided evenly into 2 groups: a CO-treated
group and a control group. In the CO-treated group, animals were continu-
ously treated with inhaled CO from the time of intubation until 2 hours after
reperfusion. The time of CO inhalation before the left bronchus was
clamped was approximately 150 minutes, with a total CO inhalation time
of 360 minutes. Total surgical time was approximately 7 hours for both
experimental groups.
IRI
After anesthesia, the animals were mechanically ventilated with
a mixture of 100% oxygen and 1% to 3% isoflurane at a tidal volume
of 15 to 20 mL/kg and a respiratory rate of 12 to 15 breaths per minute
(MD-705 XL; Senko Medical Instrument Mfg Co, Ltd, Tokyo, Japan).
A positive end-expiratory pressure of 5 cm H2O was added at the time
of reperfusion. A left thoracotomy was performed in the fifth intercostalThe Journal of Thoracic and Carspace. After the intravenous administration of heparin, 300 IU/kg, warm
ischemia was induced by clamping the left pulmonary artery, veins, and
left main bronchus. Simultaneously, the left main bronchus was dissected,
thereby collapsing the left lung. After 90 minutes of ischemic time, the left
main bronchus was reanastomosed. The pulmonary vessels were then un-
clamped to permit reperfusion, and a thoracotomy tube was placed. Open
lung biopsy specimens of the left lung were obtained 2 hours and then 2,
7, 28, and 56 days after reperfusion. So that sampling error would be min-
imized, relatively large specimens (ie, 15–20 g) were obtained from the
inferior lingular segment and anterior/lateral basal segment of the left
lung.
Assessment of Lung Injury by Blood Gas Analysis
Arterial blood was obtained before the operation and then 10, 30, 60, and
120 minutes after reperfusion through a left carotid arterial line. Blood was
analyzed with a CO-Oximeter.
Assessment of Lung Injury by Chest X-Ray (CXR)
Films
CXR films were taken 2, 7, 28, and 56 days after IRI. CXR films were
evaluated by a blinded radiologist using the composite 4-point scoring
system described by Murray and associates17 in 1988: 0 ¼ no alveolar con-
solidation, 1¼ alveolar consolidation in one quadrant, 2¼ alveolar consol-
idation in two quadrants, 3¼ alveolar consolidation in three quadrants, and
4 ¼ alveolar consolidation in all four quadrants.
Assessment of Lung Injury by Histopathologic
Examination
Biopsy samples were analyzed by a blinded pathologist using light
microscopy and transmission electron microscopy. Samples analyzed
by light microscopy were fixed in 10% formalin, embedded in paraffin,
and stained with hematoxylin and eosin and elastica–Masson Goldner
stain. A semiquantitative score was calculated on the basis of the evalu-
ation of cell infiltration, intra-alveolar edema, fibrin exudation, and hem-
orrhage. The morphologic changes were graded on the basis of the score
described by Mu¨ller and colleagues18: 0 ¼ normal; 1 ¼ mild; 2 ¼ mod-
erate; and 3 ¼ severe changes. Twenty fields of the slides at 3400 were
scored and calculated in each lung sample without prior knowledge of
the clinical or histologic findings. For electron microscopy, tissue was
fixed in 2.5% glutaraldehyde in phosphate buffer (pH 7.4), postfixed
with 1% osmium tetroxide, dehydrated, and embedded in Epon 812.
Ultrathin sections were stained with uranyl acetate and lead citrate and
examined with a Hitachi H7500 electron microscope (Hitachi, Tokyo,
Japan). For electron microscopy, a semiquantitative score was calculated
on the basis of the evaluation of swelling of endothelial cells and alve-
olar epithelial cell desquamation. Twenty fields of the slides at 35000
were scored in each lung sample using the same grading system as
used for light microscopy.Measurement of Serum Interleukin (IL) 1b, IL-6, and
High-Mobility Group Box 1 (HMGB1) Levels
The serum concentrations of IL-1b, IL-6, and HMGB1 were measured
frequently perioperatively and then 1, 2, 4, and 7 days after reperfusion
by enzyme-linked immunosorbent assay as described by the manufacturer
(IL-1b, IL-6: R&D Systems, Minneapolis, Minn; HMGB1: Shino-Test
Corporation, Sagamihara, Japan).Statistical Analysis
Results were expressed as means  SEM. Group comparisons were
performed by the Student t test, the Mann–Whitney U test, or analysis of
variance, as appropriate.diovascular Surgery c Volume 139, Number 6 1595
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FIGURE 1. Percent carboxyhemoglobin (COHb) in the blood during and
after carbon monoxide (CO) inhalation.
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CO Inhalation Increases COHb Levels
Baseline COHb levels were 0.5%  0.2%. With the
inhalation of CO at approximately 250 ppm in the CO-treated
group, COHb levels rose rapidly and stabilized at 12.1% 
0.3%. When CO treatment was discontinued 2 hours after re-
perfusion, COHb levels dropped rapidly (Figure 1). COHb
levels in the control group remained at baseline throughout
the experiment. Low-dose CO inhalation had no apparent ef-
fect on animal behavior after the operation. Blood pressure
(systolic/diastolic 105/69  6 mm Hg in the CO-treated
group vs 112/79  16 mm Hg in the control group 2 hours
after reperfusion) or liver or renal function (alanine amino-
transferase/creatinine: 21  8 IU/L 1.0  0.0 mg/dL in the
CO-treated group vs 29 4 IU/L 0.8 0.2 mg/dL in the con-
trol group 1 day after reperfusion).CO Inhalation Improves Short-Term Oxygenation
After IRI
Arterial oxygen tension (PaO2) was used to characterize
the effect of IRI on lung function.19 In the control group,
90 minutes of warm ischemia resulted in a significant
decrease in PaO2, from 513  22 mm Hg before ischemia
to 227  57 mm Hg 2 hours after reperfusion (P ¼ .032;
Figure 2, A). Moreover, despite successful extubation and
recovery from anesthesia, 1 animal died of severe pulmo-
nary edema 4 hours after reperfusion after discharging
a significant amount of foamy, bloody sputum. The clinical
diagnosis of pulmonary edema was later confirmed by
pathologic examination. In sharp contrast, animals in the
CO-treated group had no significant change in PaO2 despite
90 minutes of warm ischemia (PaO2 481 18 mm Hg before
ischemia, PaO2 454  34 mm Hg 2 hours after reperfusion;
P ¼ .56) (Figure 2, B). All animals in the CO-treated group
survived the experimental period.CO Inhalation Inhibits the Development of
Pulmonary Infiltrates on CXR Films
CXR films of animals in the control group revealed
decreased lung expansion and increased pulmonary infil-
trates 2 days after reperfusion in the left lung only (Figure 3,
A). In contrast, the CXR films of the CO-treated group
showed well-expanded lungs bilaterally with few infiltrates
2 days after IRI (Figure 3, B). The quantitative CXR score of
the left lung 2 days after reperfusion was 1.0  0.4 in the
CO-treated group and 2.7  0.3 in the control group. No
significant differences between the CXR films of the groups
were observed 7, 28, or 56 days after IRI.CO-Treated Animals Had Fewer Histopathologic
Changes by Light Microscopy
Pathologic examination of biopsy specimens taken 2
hours after reperfusion in the control group showed focal1596 The Journal of Thoracic and Cardiovascular Surcellular infiltration, including neutrophils, slight intra-alveo-
lar edema, mild hemorrhage, and fibrin exudation (Figure 4,
A). Two days after reperfusion, there was significant damage
to alveolar endothelial cells with intra-alveolar edema,
hemorrhage, and fibrin exudates (Figure 4, B). Neutrophil
infiltration was evident in both the alveolar capillaries and
the small pulmonary arterioles (Figure 4, C). Fibrin exudates
that form as a result of alveolar wall damage were also seen
in the control group (Figure 4, D). In contrast, lung biopsy
specimens from the CO-treated animals 2 hours after reper-
fusion showed almost normal lung histologic features (Fig-
ure 4, E). Only mild intra-alveolar edema (Figure 4, F) and
cellular infiltration (Figure 4, G) were observed 2 days after
reperfusion. Fibrin exudates were significantly decreased in
the CO-treated group compared with in the control group 7
days after reperfusion (Figure 4, H). Histopathologic scores
of biopsy samples are detailed in Table 1.CO Inhalation Protects Vascular Endothelial Cells
From IRI
Changes in cell morphology that result from IRI were
evaluated by electron microscopic examination of lung
biopsy samples taken 2 hours and 2 days after reperfusion.
In biopsy samples from the control group, neutrophil infil-
trates were seen in the alveolar capillaries, and endothelial
cells showed marked swelling with vacuolization and disor-
ganization of intracellular architecture 2 hours after reperfu-
sion (Figure 5, A). Two days after IRI, biopsy specimens
from the control group showed multiple patchy areas of
alveolar wall thickening with deposits of collagen fibrils in
the alveolar walls. Damaged alveolar capillaries, fluid and
blood leakage into the alveolar space, intra-alveolar fibrin
exudates, marked interstitial edema, and neutrophil infiltra-
tion into alveolar capillaries and surrounding interstitium
were seen (Figure 5, B). In contrast, biopsy specimens
from CO-treated animals revealed only mild swelling of
endothelial cells with mild edema of alveolar walls 2 hoursgery c June 2010
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FIGURE 2. Arterial blood gas analysis before and after 90 minutes of warm ischemia. A, In the control group, PaO2 decreased from 513 22 mm Hg before
ischemia to 227 57 mm Hg 2 hours after reperfusion (P¼ .032). B, In the carbon monoxide (CO)-treated group, there was no significant change in PaO2 after
ischemia–reperfusion injury (481  18 mm Hg before ischemia; 454  34 mm Hg 2 hours after reperfusion; P ¼ .56).
Sahara et al Evolving Technology/Basic Science(Figure 5, C) and 2 days (Figure 5, D) after reperfusion.
Near-normal ultrastructure was maintained after IRI. Histo-
pathologic scores of biopsy samples evaluated by electron
microscopy are detailed in Table 2.
CO Inhalation Inhibits the Production of
Proinflammatory Mediators in Response to IRI
Serum cytokine levels were measured to characterize the
inflammatory response to IRI and evaluate the effect of CO
on that response. Sequential measurements of systemic
early-phase cytokine levels (IL-1b, IL-6) showed that the
concentrations of these proteins increased after IRI in both
groups, peaking 1 day after reperfusion in the control group
and 2 hours after reperfusion in the CO-treated group.
The concentration of IL-1b 2 days after reperfusion in the
CO-treated group was significantly lower than in the controlFIGURE 3. Representative chest x-ray films taken 2 days after ischemia–reper
infiltrates in the left lung. B, In the carbon monoxide–treated group, few pulmo
The Journal of Thoracic and Cargroup (9  4 pg/mL vs 43  14 pg/mL; P ¼ .044; Figure 6,
A). The concentration of IL-6 in the control group increased
substantially to 130  43 pg/mL 1 day after reperfusion. In
contrast, the concentration of IL-6 in the control group at the
same time was only 34 9 pg/mL (P¼ .055). IL-6 levels in
both groups declined 2 days after reperfusion (2.1  1.5 pg/
mL in the CO-treated group vs 30  9 pg/mL in the control
group; P ¼ .019; Figure 6, B). HMGB1 has recently been
reported to be an early mediator of inflammation and cell
injury after IRI. The peak concentration of HMGB1 in the
control group (14  6 ng/mL) was observed 2 days after
reperfusion (Figure 6, C). In contrast, the HMGB1 concen-
tration 2 days after reperfusion in the CO-treated group was
only 0.4  0.1 ng/mL (P ¼ .037; Figure 6, C). The concen-
trations of IL-1b, IL-6, and HMGB1 returned to baseline by
4 days after reperfusion (data not shown).fusion injury. A, In the control group, the films revealed diffuse pulmonary
nary infiltrates are seen.
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TABLE 1. Histologic scores of lung biopsy specimens based on light
microscopy
Two hours
after reperfusion
Two days
after reperfusion
Control
(n ¼ 4)*
CO-treated
(n ¼ 4)
Control
(n ¼ 3)*
CO-treated
(n ¼ 4)
Infiltrating cells 1.6  0.2 0.5  0.0y 2.3  0.4 1.1  0.1
Intra-alveolar edema 1.0  0.4 0.3  0.0y 1.7  0.7 0.5  0.2
Fibrin exudation 1.0  0.3 0.2  0.1y 2.2  0.4 0.5  0.2
Intra-alveolar
hemorrhage
1.7  0.3 0.4  0.2y 2.0  0.3 0.8  0.1
CO, Carbon monoxide. Data are shown as mean  SEM. *One animal died of severe
pulmonary edema 4 hours after reperfusion. yP< .05 versus control group.
FIGURE 4. Histologic analysis by light microscopy of representative lung biopsy specimens from the control (A–D) and carbon monoxide (CO)-treated
groups (E–H). The control group showed focal cellular infiltration, slight intra-alveolar edema, mild hemorrhage, and fibrin exudation 2hours after reperfusion
(A); damaged alveolar endothelial cells, intra-alveolar edema, hemorrhage, and fibrin exudates 2 days after reperfusion (B); neutrophil infiltration in both the
intra-alveolar space and small pulmonary arterioles 2 days after reperfusion (C); and massive alveolar exudates and focal hyaline membrane formation 7 days
after reperfusion (D). In dramatic contrast, lung biopsy specimens in the CO-treated animals revealed nearly normal structure 2hours after reperfusion (E);
mild swelling of the alveolar wall (F) and neutrophil infiltration 2 days after reperfusion (G); and reversion to near-normal histology 7 days after reperfusion
(H). A, B, D to F, and H: Elastica-Masson Goldner stain (EMG; 3200). C and G: Hematoxylin and eosin stain (H&E; 3600).
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Graft quality has a major impact on the short- and long-
term outcomes of transplantation. The donor’s baseline
health and cause of death, as well as the conditions of organ
procurement, storage, and transplantation, all affect suscep-
tibility to IRI. In transplanted lungs, IRI takes the form of
nonspecific inflammatory changes that result in cellular
structural damage, the increased expression of MHC anti-
gens20 and proinflammatory cytokines,21 and the activation
of proapoptotic pathways in the graft, all of which begin
before organ transplantation.22 The prevention of IRI in
the graft is important for both early and long-term graft func-
tion, particularly when using organs from marginal donors.
In this study, we established a clinically relevant large
animal model of standardized lung ischemia and reperfusion
that evaluates the functional and biochemical aspects of IRI
in vivo. We induced 90 minutes of warm ischemic injury to
one lung, with concurrent dissection of the associated main
bronchus. This injury led to a reduction in PaO2 in the control
group from 513  22 mm Hg before ischemic injury to 227
 57 mm Hg after ischemia, a 50% reduction that persisted
for 2 hours after reperfusion in the control group. IRI in the
control group was associated with the development of sig-
nificant pulmonary infiltrates on CXR films and widespread
tissue damage, as well as the rapid death of 1 animal from
severe pulmonary edema. In contrast, the continuous admin-
istration of inhaled low-dose CO to the naı¨ve lung through-
out the operation, and to the ischemic lung both before and
after IRI, led to significant improvements in oxygenation
and cellular integrity. CO inhalation also reduced the num-1598 The Journal of Thoracic and Cardiovascular Surber of pulmonary infiltrates and the elevation of serum con-
centrations of the proinflammatory cytokines IL-1b, IL-6,
and HMGB1 after IRI.
Recent work has demonstrated that constitutive heme
oxygenase expression and the endogenous generation of
CO help maintain the integrity of cells and the physiologic
functions of organs via anti-inflammatory, antiapoptotic,
and antiproliferative effects.10 CO also exerts potent protec-
tive effects on blood vessels; it optimizes microcirculation
by promoting vasodilation and inhibiting platelet activa-
tion.10 Furthermore, increased levels of CO—as a result of
enhanced endogenous production through heme oxygen-
ase-1 induction or the exogenous delivery of CO by gas
inhalation, CO-releasing molecules, the pro-drug methylene
chloride, or in soluble form in a preservation solution—have
been shown to exert cytoprotective effects in more thangery c June 2010
TABLE 2. Histologic scores of lung biopsy specimens based on
electron microscopy
Two hours
after reperfusion
Two days
after reperfusion
Control
(n ¼ 4)*
CO-treated
(n ¼ 4)
Control
(n ¼ 3)*
CO-treated
(n ¼ 4)
Swelling of endothelial cells 1.9  0.2 1.0  0.2y 1.8  0.2 0.7  0.1
Alveolar epithelial cell
desquamation
0.4  0.1 0.1  0.0y 1.2  0.4 0.0  0.0
CO, Carbon monoxide. Data are shown as mean  SEM. *One animal died of severe
pulmonary edema 4 hours after reperfusion. yP< .05 versus control group.
FIGURE 5. Histologic analysis by electron microscopy of representative lung biopsy specimens. A, In the control group 2 hours after reperfusion, electron
microscopy revealed edema of alveolar walls, neutrophil infiltration in the alveolar capillaries, and marked swelling of endothelial cells. B, Two days after
reperfusion, the alveolar walls were thickened, with fluid and blood leakage into the alveolar spaces. Damaged and destroyed alveolar capillaries are seen. C,
In the carbon monoxide (CO)-treated animals, pathologic changes were limited to mild swelling of endothelial cells and edema of the alveolar walls 2 hours
and 2 days (D) after reperfusion. Original magnification: A, 35000; B and D, 34000; and C, 36000.
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including models of lung, heart, kidney, small intestine,
liver, and islet cell transplantation.10 In this study, we
showed that low-dose CO inhalation limits acute IRI to
lungs in a preclinical large animal model.
Experimental and clinical data suggest that IRI during
transplantation occurs in a biphasic pattern: the early phase
occurs within 15 minutes of graft reperfusion and depends
primarily on donor characteristics, such as the number of
resident alveolar macrophages in the graft; the delayed phase
occurs over the ensuing 24 hours and depends primarily on
recipient factors, including the infiltration and activity of
recipient neutrophils and lymphocytes.23,24 Abundant pul-
monary resident macrophages are a source of multiple proin-
flammatory mediators, including IL-1b, tumor necrosis
factor-a, and IL-6. These cells can cause immediate direct
injury to cells and can prompt neutrophil activation, migra-
tion, and extravasation into the alveolar interstitial space.
The decrease in serum levels of IL-1b and IL-6 reported in
our study suggests that the protective effects of CO are
mediated in part by the downregulation of the proinflamma-
tory mediators normally produced by resident macrophages.The Journal of Thoracic and CarCO effectively limits the proinflammatory cytokine/chemo-
kine response of macrophages to ischemia and reperfusion,
resulting in decreased paracrine activation of other constitu-
ent lung cell populations and a decrease in the recruitment of
circulating inflammatory cells.
The importance of reactive oxygen species such as su-
peroxide anion and hydrogen peroxide has been recognized
in lung IRI. Reactive oxygen species are highly unstable
and react with the lipid component of the cell membrane,
which can range from increased permeability to cell lysis.1diovascular Surgery c Volume 139, Number 6 1599
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FIGURE 6. Serum levels of inflammatory cytokines. Two days after reperfusion, serum cytokine levels were significantly lower in the carbon monoxide (CO)-
treated animals than in the control animals: A, IL-1b: 9 4 pg/mL versus 43 14 pg/mL; P¼ .044; B, IL-6: 2.1 1.5 pg/mL versus 30 9 pg/mL; P¼ .019;
C, HMGB1: 14 6 ng/mL versus 0.4 0.1 ng/mL;P¼ .037. Data are expressed as the mean SEM. *P<.05 between the CO-group (solid bars) and control
group (open bars). IL, Interleukin; HMGB1, high-mobility group box 1.
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reactive oxygen species during lung ischemia/reperfusion
depends on the nicotinamide adenine dinucleotide phos-
phate system, which is present mainly on activated neutro-
phils, monocytes/macrophages, and endothelial cells and
catalyzes the reduction of oxygen into hydrogen peroxide
and superoxide anion.1 The protective effect of CO on in-
flammatory cells such as neutrophils or macrophages and
vascular endothelial cells could reduce the production of re-
active oxygen species during IRI in this model. To evaluate
functional characteristics of the microvasculature by mea-
suring microvascular reactivity directly would be very use-
ful in further understanding the mechanism of CO activity
on endothelial cells.25 In addition, the strong affinity of CO
for the heme moiety of nicotinamide adenine dinucleotide
phosphate oxidase could modulate reduction–oxidation
signaling and reduce the production of reactive oxygen
species.26
Extracellular HMGB1 is a potent inflammatory stimulator
that acts by promoting cytokine production by monocytes,
macrophages, dendritic cells, and endothelial cells.27 It is
released into the extracellular milieu either passively from
damaged or necrotic cells or actively by secretion from acti-
vated monocytes and macrophages. We found that CO inha-
lation almost eliminated the increase in serum levels of
HMGB1 seen in the control group. Further studies are
necessary, however, to determine the mechanism of
HMGB1 secretion in this model. We are currently carrying
out experiments to determine whether direct inhibition of
HMGB1 expression prevents IRI in this model.
CO binds hemoglobin with an affinity that is 240 times
greater than that of oxygen, thereby interfering with the
oxygen delivery system of the body. COHb levels correlate
well with clinical symptoms of CO poisoning in humans;
levels of 10% to 30% can cause minor transient symptoms
including headache, dizziness, and shortness of breath; death
occurs at COHb levels between 50% and 80%.8 In murine
studies, no deleterious side effects have been reported from
short- or long-term CO inhalation at dosages between 20 and1600 The Journal of Thoracic and Cardiovascular Sur500 ppm (COHb 10%–25%).10 Similarly, our study and
others have shown no adverse effects of CO inhalation at
the dosages of 250 ppm with 10% to 15% COHb in minia-
ture swine.14 One study in humans reported that inhalation
of 500 ppm CO for 1 hour, which correlated with COHb
levels of about 7%, produced no clinical symptoms.28
Short-term treatment with low-dose inhaled CO in the set-
ting of careful monitoring of COHb levels may be clinically
applicable, but only after further studies in large animals
establish a clinically acceptable risk profile for short-term,
low-dose CO inhalation in humans.
CO inhalation by donors and recipients during the perio-
perative period may decrease IRI during clinical lung trans-
plantation. Donor pretreatment with inhaled CO before
organ harvest could be accomplished in a clinical setting,
potentially decreasing the effects of warm ischemia and
prolonging the tolerable ischemic interval with little risk of
adverse effects on the recipient. CO could be easily admin-
istered to lung donors after the declaration of brain death or
even after cardiac death, during the time between expected
circulatory arrest and the infusion of a cold preservative
solution. Although it is difficult to conclude from this in
situ lung IRI model whether we should ventilate the donor
or the recipient or both with CO to prevent IRI, experiments
in large animal models of lung transplantation would be use-
ful to determine whether treatment with CO of the donor
alone improves relevant outcomes.
In conclusion, we have shown that the perioperative
administration of low-dose inhaled CO decreases warm
IRI in lungs in miniature swine. The rather dramatic effect
of size seen in this study, as well as the ease with which CO
inhalation could be translated to a clinical setting, suggest
the potential for CO inhalation to have a powerful therapeu-
tic effect in reducing IRI in lung transplantation in humans.We thank Drs Hiroshi Date, Toru Bando, and Adam Griesemer
for their helpful advice and review of this manuscript. We also
thank Shino-Test Corporation, Sagamihara, Japan, for generously
providing the HMGB1 enzyme-linked immunosorbent assay kit II.gery c June 2010
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